Exact Mass: 520.1251936
Exact Mass Matches: 520.1251936
Found 268 metabolites which its exact mass value is equals to given mass value 520.1251936
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mometasone furoate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C29629 - Combination Medication > C29639 - Topical Preparation > C29505 - Topical Corticosteroid C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D000893 - Anti-Inflammatory Agents D018926 - Anti-Allergic Agents D003879 - Dermatologic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 2834
Latamoxef
C20H20N6O9S (520.1012430000001)
Broad- spectrum beta-lactam antibiotic similar in structure to the cephalosporins except for the substitution of an oxaazabicyclo moiety for the thiaazabicyclo moiety of certain cephalosporins. It has been proposed especially for the meningitides because it passes the blood-brain barrier and for anaerobic infections. [PubChem] J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Pseudohypericin
Pseudohypericin is an ortho- and peri-fused polycyclic arene. Pseudohypericin is a natural product found in Hypericum bithynicum, Hypericum linarioides, and other organisms with data available. D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors
3,3',5-Trihydroxy-4'-methoxy-6,7-methylenedioxyflavone 3-glucuronide
3,3,5-Trihydroxy-4-methoxy-6,7-methylenedioxyflavone 3-glucuronide is found in green vegetables. 3,3,5-Trihydroxy-4-methoxy-6,7-methylenedioxyflavone 3-glucuronide is a constituent of spinach.
3',4',5-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4'-glucuronide
3,4,5-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide is found in green vegetables. 3,4,5-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide is isolated from spinach (Spinacia oleracea). Isolated from spinach (Spinacia oleracea). 3,4,5-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide is found in green vegetables and spinach.
Melitric acid B
Melitric acid B is found in herbs and spices. Melitric acid B is a constituent of Melissa officinalis (lemon balm). Constituent of Melissa officinalis (lemon balm). Melitric acid B is found in tea and herbs and spices.
Eujambolin
Eujambolin is found in fruits. Eujambolin is a constituent of Eugenia jambolana (jambolan). Constituent of Eugenia jambolana (jambolan). Eujambolin is found in fruits.
2',7'-Bis-(2-carboxyethyl)-6-carboxyfluorescein
Bathocuproine disulfonate
Ethyl 4-[5-[(2-ethoxypyrimidin-5-yl)methyl]-2-[(4-fluorophenyl)methylsulfanyl]-4-oxopyrimidin-1-yl]benzoate
4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate
JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH[1][2].
Mometasone furoate
Pseudohypericin
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents D004791 - Enzyme Inhibitors
1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2-(carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-
5,3',4'-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4'-glucuronide
5,3,4-trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide is a member of the class of compounds known as flavonoid o-glucuronides. Flavonoid o-glucuronides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to glucuronic acid. 5,3,4-trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide is slightly soluble (in water) and a moderately acidic compound (based on its pKa). 5,3,4-trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide can be found in spinach, which makes 5,3,4-trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide a potential biomarker for the consumption of this food product.
5,2-Dihydroxy-7,8,6-trimethoxyflavone 2-glucuronide
5,3,4-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide
Quercetin 5,7,3,4-tetramethyl ether 3-galactoside
Lethedoside B
Mearnsetin 3-O-(4-O-acetyl)-alpha-L-rhamnopyranoside
6-Hydroxytricetin 6,7,3,5-tetramethyl eter 5-rhamnoside
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
(2S,3R)-2-(1,3-benzodioxol-5-yl)-3-[(beta-D-glucopyranosyloxy)methyl]-2,3-dihydro-7-methoxybenzofuran-5-carboxylic acid methyl ester|cedralin B
4-O-benzoyl-beta-D-xylopyranosyl(1->2)-7-O-benzoyl-beta-D-glucopyranoside
4-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]swertiamarin
6-O-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]swertiamarin|6-O-[(E)-coumaroyl]swertiamarin
5,7-dihydroxy-3,4,5-trimethoxyflavone 7-O-beta-D-glucuronide
(S)-(-)-5,7,3,5-tetrahydroxyflavanone 7-O-(butyl beta-D-glucopyranosiduronate)|garccowaside B
5-Hydroxy-7,8,2,5-tetramethoxyflavone 5-O-glucoside
(+)-fatouain G|(+)-threo-6-(1,2-dihydroxy-3-methylbut-3-enyl)-8-(7-hydroxy-6-(3-methylbut-2-enyl)-2-oxo-[2H]-chromen-8-yloxy)-7-methoxy-[2H]-chromen-2-one
8,3-dihydroxy-3,7,4-trimethoxy-6-O-beta-D-glucopyranosyl flavone
1-O-formylmethyl rocaglate|Rocaglamide derivative 5
Pedaliin 6-acetate
Pedaliin 6-acetate is a natural product found in Dracocephalum tanguticum with data available.
6-O-Cinnamoyl-8-epikingisidic acid
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid
[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4-oxo-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-8-yl] acetate
[(2S,3R,4S,5R,6S)-6-[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl] acetate
C25H28O12_Cyclopenta[c]pyran-4-carboxylic acid, 1,4a,5,6,7,7a-hexahydro-6-hydroxy-1-[[6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]-beta-D-glucopyranosyl]oxy]-7-methylene
C25H28O12_(2E)-3-(2-{[6-O-(3,4,5-Trimethoxybenzoyl)-beta-D-glucopyranosyl]oxy}phenyl)acrylic acid
[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4-oxo-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxychromen-8-yl] acetate
1-[4,5-dihydroxy-6-(hydroxymethyl)-3-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxyoxan-2-yl]oxy-6-hydroxy-7-methylidene-4a,5,6,7a-tetrahydro-1H-cyclopenta[c]pyran-4-carboxylic acid_major
Cys Asp Phe His
Cys Asp His Phe
Cys Phe Asp His
Cys Phe His Asp
Cys His Asp Phe
Cys His Phe Asp
Cys His Met Met
Cys Met His Met
Cys Met Met His
Asp Cys Phe His
Asp Cys His Phe
Asp Glu Glu Glu
Asp Phe Cys His
Asp Phe His Cys
Asp His Cys Phe
Asp His Phe Cys
Glu Asp Glu Glu
Glu Glu Asp Glu
Glu Glu Glu Asp
Phe Cys Asp His
Phe Cys His Asp
Phe Asp Cys His
Phe Asp His Cys
Phe His Cys Asp
Phe His Asp Cys
His Cys Asp Phe
His Cys Phe Asp
His Cys Met Met
His Asp Cys Phe
His Asp Phe Cys
His Phe Cys Asp
His Phe Asp Cys
His Met Cys Met
His Met Met Cys
Met Cys His Met
Met Cys Met His
Met His Cys Met
Met His Met Cys
Met Met Cys His
Met Met His Cys
JZL 184
JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH[1][2].
Nap-Nap-OH
C31H24N2O6 (520.1634283999999)
3',4',5-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4'-glucuronide
Eujambolin
3,3',5-Trihydroxy-4'-methoxy-6,7-methylenedioxyflavone 3-glucuronide
Melitric acid B
ethyl (Z,Z)-9,9-dibutyl-4,7,11-trioxo-3,8,10-trioxa-9-stannatetradeca-5,12-dien-14-oate
[[4-amino-5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidin-2-yl]amino]-(3-ethoxy-4-hydroxyphenyl)methanesulfonic acid
4,4-(4,4-Isopropylidenediphenoxy)diphthalic Anhydride
Eprosartan mesylate
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D057912 - Angiotensin II Type 2 Receptor Blockers D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Eprosartan mesylate (SKF-108566J) is a selective, competitive, nonpeptid and orally active angiotensin II receptor antagonist, used as an antihypertensive. Eprosartan mesylate binds angiotensin II receptor with IC50s of 9.2 nM and 3.9 nM in rat and human adrenal cortical membranes, respectively[1].
METHYL-3-[2-(4-AMINOBENZOYL)ACETAMINO]-4-[3,5-DICARBOXYMETHYL)-PHENOXY]-BENZOATE
(1R,2R)-2-AMINO-CYCLOHEXANECARBOXYLICACIDETHYLESTER
C28H28N2O4S2 (520.1490408000001)
2,24,4-tetrahydroxybenzophenone and 2,2-dihydroxy-4,4-dimethoxybenzophenone
(1S,2S)-2-AMINOCYCLOHEXANECARBOXYLICACID
C28H28N2O4S2 (520.1490408000001)
bis(pentamethylcyclopentadienyl)hafnium dichloride
Spiradoline mesylate
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Bathocuproine disulfonate
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents D064449 - Sequestering Agents > D002614 - Chelating Agents
3-Methoxy-3,5-dihydroxy-4-(beta-D-glucopyranuronosyloxy)-6,7-(methylenedioxy)flavone
7-((Carboxy(4-hydroxyphenyl)acetyl)amino)-7-methoxy-(3-((1-methyl-1H-tetrazol-5-YL)thio)methyl)-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C20H20N6O9S (520.1012430000001)
[(2S,3R,4S,5R,6S)-6-[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-2-methyloxan-3-yl] acetate
1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2-(carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-
3-[(2S,3R,4S,5R)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3-oxopropanoic acid
1-[3-[(5-bromo-2-pyridinyl)-[(4-chlorophenyl)methyl]amino]propyl]-3-[3-(1H-imidazol-5-yl)propyl]thiourea
3,4,5-Trihydroxy-6-[4-oxo-1-(5,6,7-trimethoxy-4-oxochromen-2-yl)cyclohexa-2,5-dien-1-yl]oxyoxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[2-[9-(3-methylbut-2-enoyloxy)-2-oxo-8,9-dihydrouro[2,3-h]chromen-8-yl]propan-2-yloxy]oxane-2-carboxylic acid
(2R,3R,4R,5R)-4-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
3-oxo-3-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[[(2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-7-yl]oxy]oxan-2-yl]methoxy]propanoic acid
(2R,3R,4R,5R)-4-[(2S,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,3,5,6-tetrahydroxyhexanoic acid
[(8S,9S,10S,11R,13S,14S,16R,17S)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate
4,7,11-Trimethyl-18-(2-methylsulfanylethyl)-6-oxa-13,20-dithia-3,10,17,22,23,24-hexazatetracyclo[17.2.1.15,8.112,15]tetracosa-1(21),5(24),7,12(23),14,19(22)-hexaene-2,9,16-trione
Latamoxef
C20H20N6O9S (520.1012430000001)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
4-Nitrophenyl 4-[bis(2H-1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate
JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH[1][2].
3,4,5-Trihydroxy-3-methoxy-6,7-methylenedioxyflavone 4-glucuronide
Loniphenyruviridoside B, (rel)-
A natural product found in Lonicera japonica.
Moxalactam
C20H20N6O9S (520.1012430000001)
A broad-spectrum oxacephem antibiotic in which the oxazine ring is substituted with a tetrazolylthiomethyl group and the azetidinone ring carries methoxy and 2-carboxy-2-(4-hydroxyphenyl)acetamido substituents.
(1s,4s)-4-bromo-1-{[(1s,4s,5s,6r,9s,10s)-9-bromo-10-hydroxy-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-4-yl]methyl}-3,3-dimethylcyclohexyl acetate
(2r,3s,4r,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
16-{[3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-2,5,18-trihydroxy-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),11,14,16,18-hexaen-20-one
(2s,3r,4s,5s,6r)-2-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate
4-bromo-1-({9-bromo-10-hydroxy-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-4-yl}methyl)-3,3-dimethylcyclohexyl acetate
2-(3,4-dimethoxyphenyl)-5,7-dimethoxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-{[5-hydroxy-4-oxo-2-(3,4,5-trimethoxyphenyl)chromen-7-yl]oxy}oxane-2-carboxylic acid
7-(3-chloro-4-hydroxy-2-methoxy-6-methylphenyl)-2,4,9-trihydroxy-12,12-dimethyltetracene-5,6,11-trione
(1s,4s)-4-bromo-1-{[(1s,4s,5s,6r,9s,10r)-9-bromo-10-hydroxy-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-4-yl]methyl}-3,3-dimethylcyclohexyl acetate
(2s,3r,4s,5r,6r)-4-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl acetate
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
[(2s,3s)-2-[4-(acetyloxy)-3-methoxyphenyl]-12-methoxy-10-oxo-2,3-dihydro-1,4,5-trioxatetraphen-3-yl]methyl acetate
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl (2r)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoate
methyl 5-(furan-3-yl)-11-(4-hydroxybenzoyloxy)-4,10-dimethyl-3,14-dioxo-15-oxatetracyclo[6.5.2.0¹,⁹.0²,⁶]pentadec-2(6)-ene-7-carboxylate
14-hydroxy-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2(10),3,8,16,21-hexaen-11-yl benzoate
angustifolin c
{"Ingredient_id": "HBIN016138","Ingredient_name": "angustifolin c","Alias": "NA","Ingredient_formula": "C29H28O9","Ingredient_Smile": "CC1C(C(C2=CC3=C(C(=C2C4=C(C5=C(C=C4C1O)OCO5)OC)OC)OCO3)OC(=O)C6=CC=CC=C6)C","Ingredient_weight": "520.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1248","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "102316918","DrugBank_id": "NA"}
methyl 2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-3-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydro-1-benzofuran-5-carboxylate
(2s,3r,4s,5s,6s)-6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
3,4,5-trihydroxy-6-{[5-hydroxy-4-oxo-2-(3,4,5-trimethoxyphenyl)chromen-7-yl]oxy}oxane-2-carboxylic acid
6-amino-3,21,28-trihydroxy-24-methoxy-7-methyl-14,16,26-trioxa-6-azaheptacyclo[15.11.1.0²,¹¹.0⁴,⁹.0¹³,²⁹.0¹⁸,²⁷.0²⁰,²⁵]nonacosa-1(29),2(11),3,7,9,17,20(25),27-octaene-5,19-dione
1,2,3,8-tetramethoxy-6-methyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}anthracene-9,10-dione
[6-({4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-3,4,5-trihydroxyoxan-2-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate
methyl (2s,3r)-2-(2h-1,3-benzodioxol-5-yl)-7-methoxy-3-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2,3-dihydro-1-benzofuran-5-carboxylate
(2s,3s,4s,5r,6s)-3,4,5-trihydroxy-6-[2-(5-hydroxy-7,8-dimethoxy-4-oxochromen-2-yl)-3-methoxyphenoxy]oxane-2-carboxylic acid
{2-[4-(acetyloxy)-3-methoxyphenyl]-12-methoxy-10-oxo-2,3-dihydro-1,4,5-trioxatetraphen-3-yl}methyl acetate
(6-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl acetate
(1r,2r,4s,6r)-2-{[(2e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,6-dihydroxy-4-(methoxycarbonyl)cyclohexyl 3,4,5-trihydroxybenzoate
[(2s,3s,4r,5s,6r)-6-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl 2-{[(2r,3s,4r,5r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoate
6-(2-{4,8-dimethoxy-9h-pyrido[3,4-b]indol-1-yl}ethyl)-4-methoxy-1,6-diazatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-4,7,9(16),10(15),11,13-hexaene-2,3-dione
methyl (1r,4s,5s,7s,8s,9s,10r,11r)-5-(furan-3-yl)-11-(4-hydroxybenzoyloxy)-4,10-dimethyl-3,14-dioxo-15-oxatetracyclo[6.5.2.0¹,⁹.0²,⁶]pentadec-2(6)-ene-7-carboxylate
(2s,3r,4s,5r,6r)-2-{[(3s,4r,4as)-4-ethenyl-8-oxo-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
methyl (2s,3r,4r,5s,6r)-6-(2h-1,3-benzodioxol-5-yl)-3-hydroxy-2,10,12-trimethoxy-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate
(2s,3r,4s,5r,6s)-6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
(2s,3r,4s,5s,6s)-2-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate
methyl (2s,3r,4r,5s,6r)-3-(formyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate
(2s,3r,4r,5s,6r)-3-(acetyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylic acid
(11r,12s,13r,14s)-14-hydroxy-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2(10),3,8,16,21-hexaen-11-yl benzoate
(11s,12s,13s)-12-hydroxy-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2(10),3,8,16,21-hexaen-11-yl benzoate
(2r,3s,4r,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl (2z)-3-(4-hydroxyphenyl)prop-2-enoate
2-(2,3-dimethoxyphenyl)-7,8-dimethoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
3-{[5-(benzoyloxy)-3,4-dihydroxyoxan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl benzoate
2-{[3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy}-4,6-dihydroxy-4-(methoxycarbonyl)cyclohexyl 3,4,5-trihydroxybenzoate
2-({4-ethenyl-8-oxo-3h,4h,4ah,5h,6h-pyrano[3,4-c]pyran-3-yl}oxy)-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
3-(acetyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylic acid
(2r)-3-(3,4-dihydroxyphenyl)-2-{[(2e)-3-[(3z)-3-[(3,4-dihydroxyphenyl)methylidene]-2-oxo-1,4-benzodioxin-6-yl]prop-2-enoyl]oxy}propanoic acid
(11r,12s,13r,14r)-14-hydroxy-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2(10),3,8,16,21-hexaen-11-yl benzoate
(6-{[2-(3,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-4-oxochromen-6-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl acetate
12-hydroxy-3,22-dimethoxy-12,13-dimethyl-5,7,18,20-tetraoxapentacyclo[13.7.0.0²,¹⁰.0⁴,⁸.0¹⁷,²¹]docosa-1(15),2(10),3,8,16,21-hexaen-11-yl benzoate
4-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl acetate
2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl 2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoate
(4r,5s,8r)-16-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]oxy}-2,5,18-trihydroxy-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),11,14,16,18-hexaen-20-one
[(2r,3s,4s,5r,6s)-6-{[(3s,4r,4ar)-4-ethenyl-4a-hydroxy-8-oxo-3h,4h,5h,6h-pyrano[3,4-c]pyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate
(1s,4s)-4-bromo-1-{[(1s,4s,5s,6r,9s)-9-bromo-10-hydroxy-6-methyl-11-oxatricyclo[4.3.2.0¹,⁵]undecan-4-yl]methyl}-3,3-dimethylcyclohexyl acetate
6,8-dihydroxy-3,4,5-trimethyl-1-(1,3,8-trihydroxy-6-methyl-9,10-dioxoanthracen-2-yl)-3,4-dihydro-1h-2-benzopyran-7-carboxylic acid
(3r,5s,6s)-6-{[2-(3,5-dihydroxy-4-methoxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
1-hydroxy-7-{[3,4,5-trihydroxy-6-({[5-hydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]oxy}methyl)oxan-2-yl]oxy}xanthen-9-one
2-(2,5-dimethoxyphenyl)-7,8-dimethoxy-5-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
6-[(1r,2r)-1,2-dihydroxy-3-methylbut-3-en-1-yl]-8-{[7-hydroxy-6-(3-methylbut-2-en-1-yl)-2-oxochromen-8-yl]oxy}-7-methoxychromen-2-one
methyl 3-(formyloxy)-2-hydroxy-10,12-dimethoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6.4.0.0²,⁶]dodeca-1(12),8,10-triene-4-carboxylate
2-{[5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl acetate
3,4',6-trihydroxy-5-{[(3s)-3-hydroxybutanoyl]oxy}-4-(4-hydroxyphenyl)-[1,1'-biphenyl]-2-yl 3-methylcyclopent-3-ene-1-carboxylate
6-({5-[1-(acetyloxy)ethyl]-6,9-dihydroxy-6-methyl-8-oxo-5,7-dihydroanthracen-1-yl}oxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
3-(3,4-dihydroxyphenyl)-2-[(3-{3-[(3,4-dihydroxyphenyl)methylidene]-2-oxo-1,4-benzodioxin-6-yl}prop-2-enoyl)oxy]propanoic acid
(6r,7r)-7-{[2-carboxy-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-7-methoxy-3-{[(1-methyl-1,2,3,4-tetrazol-5-yl)sulfanyl]methyl}-8-oxo-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
C20H20N6O9S (520.1012430000001)